Literature DB >> 6253458

The role of superoxide in the destruction of erythrocyte targets by human neutrophils.

S J Weiss.   

Abstract

Human neutrophils exposed to the soluble stimulus, phorbol myristate acetate, generate a flux of O2.- which can destroy human erythrocyte targets. Under optimal conditions, each neutrophil was capable of lysing almost 10 erythrocyte targets. Hemolysis was inhibited by exogenous copper-zinc or iron superoxide dismutase while neither heat-denatured enzyme nor albumin inhibited cytotoxicity. Although neutrophils can also generate H2O2, neither catalase nor a glutathione-glutathione peroxidase system inhibited hemolysis. Hemolysis was prevented by conversion of the hemoglobin to carbon monoxyhemoglobin, suggesting an intracellular mechanism of cytotoxicity. Conversion of hemoglobin to methemoglobin by nitrite treatment did not impair neutrophil-mediated hemolysis. However, nitrite-treated targets were not protected by superoxide dismutase, while exogenous catalase inhibited cytotoxicity, suggesting a potential role for H2O2 and methemoglobin. H2O2 and methemoglobin are known to interact to form an oxidant complex whose cytotoxic potential was underlined by the marked sensitivity of nitrite-treated cells to commercial H2O2. It is proposed that neutrophil-derived O2.- oxidizes oxyhemoglobin to generate methemoglobin and H2O2 which interact to form a cytotoxic complex capable of hemolyzing the erythrocyte target.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6253458

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

Review 1.  Mechanisms of oxidant-induced changes in erythrocytes.

Authors:  J R Hatherill; G O Till; P A Ward
Journal:  Agents Actions       Date:  1991-03

Review 2.  Protein degradation: the role of mixed-function oxidases.

Authors:  V Daggett
Journal:  Pharm Res       Date:  1987-08       Impact factor: 4.200

3.  Involvement of ferryl in the reaction between nitrite and the oxy forms of globins.

Authors:  Denisa Hathazi; Sonia Diana Mahuţ; Florina-Violeta Scurtu; Cristina Bischin; Corina Stanciu; Amr Ali Attia; Grigore Damian; Radu Silaghi-Dumitrescu
Journal:  J Biol Inorg Chem       Date:  2014-07-27       Impact factor: 3.358

4.  Systematic Identification of Regulators of Oxidative Stress Reveals Non-canonical Roles for Peroxisomal Import and the Pentose Phosphate Pathway.

Authors:  Michael M Dubreuil; David W Morgens; Kanji Okumoto; Masanori Honsho; Kévin Contrepois; Brittany Lee-McMullen; Gavin McAllister Traber; Ria S Sood; Scott J Dixon; Michael P Snyder; Yukio Fujiki; Michael C Bassik
Journal:  Cell Rep       Date:  2020-02-04       Impact factor: 9.423

5.  Thermal injury, intravascular hemolysis, and toxic oxygen products.

Authors:  J R Hatherill; G O Till; L H Bruner; P A Ward
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

6.  Turnover of bacterial glutamine synthetase: oxidative inactivation precedes proteolysis.

Authors:  R L Levine; C N Oliver; R M Fulks; E R Stadtman
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

7.  Role of superoxide anion in host cell injury induced by mycoplasma pneumoniae infection. A study in normal and trisomy 21 cells.

Authors:  M Almagor; I Kahane; S Yatziv
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

8.  Human polymorphonuclear leukocyte-mediated cytotoxicity against varicella-zoster virus-infected fibroblasts.

Authors:  T Ihara; S E Starr; M Ito; S D Douglas; A M Arbeter
Journal:  J Virol       Date:  1984-07       Impact factor: 5.103

9.  Mechanisms of tumour cell destruction by PMA-activated human neutrophils.

Authors:  F Dallegri; G Frumento; F Patrone
Journal:  Immunology       Date:  1983-02       Impact factor: 7.397

10.  Lung cell oxidant injury. Enhancement of polymorphonuclear leukocyte-mediated cytotoxicity in lung cells exposed to sustained in vitro hyperoxia.

Authors:  N Suttorp; L M Simon
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.